Literature DB >> 18467438

Tumor necrosis factor-alpha-mediated suppression of adipocyte apolipoprotein E gene transcription: primary role for the nuclear factor (NF)-kappaB pathway and NFkappaB p50.

Lili Yue1, John W Christman, Theodore Mazzone.   

Abstract

The adipose tissue inflammation accompanying obesity has important consequences for adipocyte lipid metabolism, and increased adipose tissue TNFalpha plays an important role for mediating the effect of inflammation on adipocyte function. Recent studies have shown that apolipoprotein E (apoE) is highly expressed in adipose tissue where it plays an important role in modulating adipocyte triglyceride metabolism, triglyceride mass, and adipocyte size. We have previously reported that TNFalpha reduces adipocyte apoE, and the current studies were undertaken to evaluate the molecular mechanism for this regulation. TNFalpha repression of adipocyte apoE gene expression required an intact nuclear factor (NF)-kappaB binding site at -43 in the apoE promoter. Site-directed mutagenesis at this site completely eliminated TNFalpha regulation of an apoE gene reporter. TNFalpha treatment activated binding of NFkappaB p50, isolated from adipocyte nuclei, to the apoE promoter. Two structurally distinct inhibitors of NFkappaB complex activation or translocation abrogated the TNFalpha effect on the apoE gene. Using chromatin immunoprecipitation assays, we demonstrated that treatment of adipocytes with TNFalpha led to increased binding of NFkappaB p50, and decreased binding of p65 and Sp1, to this region of the apoE promoter in living cells. The key role played by increased p50 binding was confirmed by p50 knockdown experiments. Reduction of p50 expression using small interference RNA completely eliminated TNFalpha-mediated reduction of endogenous adipocyte apoE gene expression. These results establish the molecular link between adipose tissue inflammation and apoE gene expression in adipocytes. The suppression of adipocyte apoE by the proinflammatory adipose tissue milieu associated with obesity will have important downstream effects on adipocyte triglyceride turnover and content.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467438      PMCID: PMC2488247          DOI: 10.1210/en.2008-0340

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

Review 1.  Apolipoprotein E secretion by macrophages: its potential physiological functions.

Authors:  T Mazzone
Journal:  Curr Opin Lipidol       Date:  1996-10       Impact factor: 4.776

2.  Functional interference of Sp1 and NF-kappaB through the same DNA binding site.

Authors:  F Hirano; H Tanaka; Y Hirano; M Hiramoto; H Handa; I Makino; C Scheidereit
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

3.  Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.

Authors:  Radina M Kostadinova; Andrea R Nawrocki; Felix J Frey; Brigitte M Frey
Journal:  FASEB J       Date:  2005-01-19       Impact factor: 5.191

4.  Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content.

Authors:  R Zechner; R Moser; T C Newman; S K Fried; J L Breslow
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

5.  DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit.

Authors:  Hancheng Guan; Shihe Hou; Robert P Ricciardi
Journal:  J Biol Chem       Date:  2005-01-07       Impact factor: 5.157

6.  Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression.

Authors:  Lili Yue; Neda Rasouli; Gouri Ranganathan; Philip A Kern; Theodore Mazzone
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

7.  Role of insulin action and cell size on protein expression patterns in adipocytes.

Authors:  Matthias Blüher; Leanne Wilson-Fritch; John Leszyk; Palle G Laustsen; Silvia Corvera; C Ronald Kahn
Journal:  J Biol Chem       Date:  2004-05-06       Impact factor: 5.157

8.  Transcriptional and post-transcriptional control of apolipoprotein E gene expression in differentiating human monocytes.

Authors:  K Basheeruddin; C Rechtoris; T Mazzone
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

9.  Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.

Authors:  Xianghuai Lu; Paul Farmer; Janet Rubin; Mark S Nanes
Journal:  J Cell Biochem       Date:  2004-07-01       Impact factor: 4.429

10.  Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression.

Authors:  H Duan; Z Li; T Mazzone
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more
  15 in total

1.  Hyperglycemia and advanced glycosylation end products suppress adipocyte apoE expression: implications for adipocyte triglyceride metabolism.

Authors:  Doris Joy Espiritu; Zhi Hua Huang; Yong Zhao; Theodore Mazzone
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-20       Impact factor: 4.310

2.  Adipose tissue depot-specific differences in adipocyte apolipoprotein E expression.

Authors:  Zhi H Huang; Doris J Espiritu; Arlene Uy; Ai-Xuan Holterman; Joseph Vitello; Theodore Mazzone
Journal:  Metabolism       Date:  2011-06-12       Impact factor: 8.694

3.  Expression of the human apoE2 isoform in adipocytes: altered cellular processing and impaired adipocyte lipogenesis.

Authors:  Zhi H Huang; Nobuyo Maeda; Theodore Mazzone
Journal:  J Lipid Res       Date:  2011-07-08       Impact factor: 5.922

4.  Endogenous adipocyte apolipoprotein E is colocalized with caveolin at the adipocyte plasma membrane.

Authors:  Lili Yue; Theodore Mazzone
Journal:  J Lipid Res       Date:  2010-12-16       Impact factor: 5.922

5.  Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation.

Authors:  Zhi H Huang; Catherine A Reardon; Godfrey S Getz; Nobuyo Maeda; Theodore Mazzone
Journal:  J Lipid Res       Date:  2014-11-24       Impact factor: 5.922

6.  Peroxisome proliferator-activated receptor {gamma} stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway.

Authors:  Lili Yue; Theodore Mazzone
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

7.  Mechanism for endogenously expressed ApoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways.

Authors:  Zhi Hua Huang; Richard D Minshall; Theodore Mazzone
Journal:  J Biol Chem       Date:  2009-09-18       Impact factor: 5.157

8.  Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo.

Authors:  Zhi Hua Huang; Desheng Gu; Theodore Mazzone
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-17       Impact factor: 4.310

9.  m6A mRNA Methylation Regulates Epithelial Innate Antimicrobial Defense Against Cryptosporidial Infection.

Authors:  Zijie Xia; Jihao Xu; Eugene Lu; Wei He; Silu Deng; Ai-Yu Gong; Juliane Strass-Soukup; Gislaine A Martins; Guoqing Lu; Xian-Ming Chen
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

Review 10.  Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome.

Authors:  Eduardo Fuentes; Francisco Fuentes; Gemma Vilahur; Lina Badimon; Iván Palomo
Journal:  Mediators Inflamm       Date:  2013-06-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.